Categories
Unlock new, well-reimbursed services: Spravato, a needle-mover for pain practices. Discover how Spravato, an FDA-approved esketamine treatment for depression, can drive significant financial reimbursement for your practice while improving patient outcomes. Join me as I meet with Yakov Kagan, CEO and co-founder of Big Leap Health, as he highlights the clinical efficacy of Spravato, its comparison to ketamine, and its financial impact. Learn key considerations for launching—whether independently or via an MSO—and actionable steps to get started, from staff training to billing essentials. Yakov will also share insights into future developments like monotherapy developments, helping your practice stay ahead in this rapidly evolving field.
For more information and to integrate Spravato into your Pain Practice go to https://www.bigleaphealth.com
Host David Rosenblum, MD Long island based anesthesiologist, David Rosenblum, MD, is one of the first interventional pain physicians in the country to integrate ultrasound guidance into his pain practice. Since 2007, he has been an international leader in the treatment of chronic pain. He has helped countless of patients suffering from back, neck, knee, shoulder, hip joint pain and has been at the forefront of regenerative pain medicine, minimally invasive pain therapies and medical education.
Patients can schedule a consultation by going to www.AABPpain.com or calling:
Brooklyn Office 718 436 7246
Garden City Office 516 482 7246
NRAP Academy also offers:
- Board Review
- Regenerative Medicine Training
- The Virtual Pain Fellowship (online training program with discount to live workshops)
Regional Anesthesia & Pain Ultrasound Course
Private Training Available
Email Info@NRAPpain.org
**Disclaimer:** The information presented in this podcast is for educational purposes only and should not be considered medical advice. Always consult a healthcare professional for medical concerns.